Hepatocellular carcinoma and evidence-based surgery.
Transplantation cannot be considered the most important therapeutic procedure for hepatocellular carcinoma (HCC). In France, no more than 2% of patients with HCC undergo a transplantation. Randomized controlled trial must assess the benefit to risk ratio of various potentially "curative" treatment procedures (transplantation, resection, radio-frequency ablation).
Braillon
Alain
A
D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000601:surgery*; D019317:Evidence-Based Medicine; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery*; D016032:Randomized Controlled Trials as Topic